Literature DB >> 19667305

The dissociation between door-to-balloon time improvement and improvements in other acute myocardial infarction care processes and patient outcomes.

Tracy Y Wang1, Gregg C Fonarow, Adrian F Hernandez, Li Liang, Gray Ellrodt, Brahmajee K Nallamothu, Bimal R Shah, Christopher P Cannon, Eric D Peterson.   

Abstract

BACKGROUND: Recent initiatives have focused on reducing door-to-balloon (DTB) times among patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. However, DTB time is only one of several important AMI care processes. It is unclear whether quality efforts targeted to a single process will facilitate concomitant improvement in other quality measures and outcomes.
METHODS: This study examined 101 hospitals (43 678 patients with AMI) in the Get With the Guidelines program. For each hospital, DTB time improvement from 2005 to 2007 was correlated with changes in composite Centers for Medicare and Medicaid Services/Joint Commission on Accreditation of Healthcare Organizations (CMS/JCAHO) core measure performance and in-hospital mortality.
RESULTS: Between 2005 and 2007, hospital geometric mean DTB time decreased from 101 to 87 minutes (P < .001). Mean overall hospital composite CMS/JCAHO core measure performance increased from 93.4% to 96.4% (P < .001), and mortality rates were 5.1% and 4.7% (P = .09) in the early and late periods, respectively. Improvement in hospital DTB time, however, was not significantly correlated with changes in composite quality performance (r = -0.06; P = .55) or with in-hospital mortality (r = 0.06; P = .58). After adjustment for patient mix, hospitals with the most improvement in DTB time did not have significantly greater improvements in either CMS/JCAHO measure performance or mortality.
CONCLUSIONS: Within the Get With the Guidelines program, DTB times decreased significantly over time. However, there was minimal correlation between DTB time improvement and changes in other quality measures or mortality. These results emphasize the important need for comprehensive acute myocardial infarction quality-improvement efforts, rather than focusing on single process measures.

Entities:  

Mesh:

Year:  2009        PMID: 19667305     DOI: 10.1001/archinternmed.2009.223

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  10 in total

1.  The management of acute myocardial infarction in the cardiological intensive care units in Italy: the 'BLITZ 4 Qualità' campaign for performance measurement and quality improvement.

Authors:  Zoran Olivari; Giuseppe Steffenino; Stefano Savonitto; Francesco Chiarella; Alessandra Chinaglia; Donata Lucci; Aldo P Maggioni; Salvatore Pirelli; Marino Scherillo; Giampaolo Scorcu; Pierluigi Tricoci; Stefano Urbinati
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2012-06

2.  Assessment and management of febrile neutropenia in emergency departments within a regional health authority-a benchmark analysis.

Authors:  D Szwajcer; P Czaykowski; D Turner
Journal:  Curr Oncol       Date:  2011-12       Impact factor: 3.677

Review 3.  The Management and Prognostic Factors of Acute Coronary Syndrome: Evidence from the Taiwan Acute Coronary Syndrome Full Spectrum Registry.

Authors:  Chun-Yuan Chu; Tsung-Hsien Lin; Wen-Ter Lai
Journal:  Acta Cardiol Sin       Date:  2017-07       Impact factor: 2.672

4.  Relation between door-to-balloon times and mortality after primary percutaneous coronary intervention over time: a retrospective study.

Authors:  Brahmajee K Nallamothu; Sharon-Lise T Normand; Yongfei Wang; Timothy P Hofer; John E Brush; John C Messenger; Elizabeth H Bradley; John S Rumsfeld; Harlan M Krumholz
Journal:  Lancet       Date:  2014-11-19       Impact factor: 79.321

5.  Randomized trial of targeted performance feedback to facilitate quality improvement in acute myocardial infarction care.

Authors:  Karen P Alexander; Tracy Y Wang; Shuang Li; Barbara L Lytle; Lara E Slattery; Sarah Calhoun; Jennifer Poteat; Matthew T Roe; John S Rumsfeld; Christopher P Cannon; Eric D Peterson
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-01-01

6.  Shorter Door-to-Balloon Time in ST-Elevation Myocardial Infarction Saves Insurance Payments: A Single Hospital Experience in Taiwan.

Authors:  Chieh-Min Fan; Chao-Lun Lai; Ai-Hsien Li; Kuo-Piao Chung; Ming-Chin Yang
Journal:  Acta Cardiol Sin       Date:  2015-03       Impact factor: 2.672

7.  Effects of Door-to-Balloon Times on Outcomes in Taiwanese Patients Receiving Primary Percutaneous Coronary Intervention: A Report of Taiwan Acute Coronary Syndrome Full Spectrum Registry.

Authors:  Chi-Cheng Lai; Kuan-Cheng Chang; Pen-Chih Liao; Chia-Tung Wu; Wen-Ter Lai; Chiung-Jen Wu; Shu-Chen Chang; Guang-Yuan Mar
Journal:  Acta Cardiol Sin       Date:  2015-05       Impact factor: 2.672

8.  Prognostic Implications of Door-to-Balloon Time and Onset-to-Door Time on Mortality in Patients With ST -Segment-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention.

Authors:  Jonghanne Park; Ki Hong Choi; Joo Myung Lee; Hyun Kuk Kim; Doyeon Hwang; Tae-Min Rhee; Jihoon Kim; Taek Kyu Park; Jeong Hoon Yang; Young Bin Song; Jin-Ho Choi; Joo-Yong Hahn; Seung-Hyuk Choi; Bon-Kwon Koo; Shung Chull Chae; Myeong Chan Cho; Chong Jin Kim; Ju Han Kim; Myung Ho Jeong; Hyeon-Cheol Gwon; Hyo-Soo Kim
Journal:  J Am Heart Assoc       Date:  2019-05-07       Impact factor: 5.501

9.  Impact of the Regional Network for AMI in the Management of STEMI on Care Processes, Outcomes and Health Inequities in the Veneto Region, Italy.

Authors:  Mario Saia; Domenico Mantoan; Marco Fonzo; Chiara Bertoncello; Marta Soattin; Milena Sperotto; Tatjana Baldovin; Patrizia Furlan; Maria Luisa Scapellato; Guido Viel; Vincenzo Baldo; Silvia Cocchio; Alessandra Buja
Journal:  Int J Environ Res Public Health       Date:  2018-09-11       Impact factor: 3.390

10.  Evaluation of STEMI Regionalization on Access, Treatment, and Outcomes Among Adults Living in Nonminority and Minority Communities.

Authors:  Renee Y Hsia; Harlan Krumholz; Yu-Chu Shen
Journal:  JAMA Netw Open       Date:  2020-11-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.